Amide derivatives bearing a cyclopropylaminoacarbonyl...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S336000, C546S029000

Reexamination Certificate

active

07943776

ABSTRACT:
The invention concerns a compound of the Formula (I), wherein Qa is heteroaryl and is substituted with halogeno; R1 and R2 are each hydrogen; and Qb is phenyl or heteroaryl, and Qb may optionally bear 1 or 2 substituents selected from hydroxy, halogeno and (1-6C)alkyl, or a pharmaceutically-acceptable salt thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.

REFERENCES:
patent: 6821965 (2004-11-01), Brown et al.
patent: 2005/0038081 (2005-02-01), Brown et al.
patent: WO 00/07980 (2000-02-01), None
patent: WO-01/70671 (2001-09-01), None
patent: WO 2004/071440 (2004-08-01), None
patent: WO 2004/098158 (2004-11-01), None
patent: WO 2005/042502 (2005-05-01), None
Boehm, J.C., et al.: “New Inhibitors of p38 Kinase” Expert Opinion of Therapleutic Patents, Ashley Publications, GB, vol. 10, No. 1, 2000, pp. 25-37, XP002259248 ISSN: 1354-3776.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amide derivatives bearing a cyclopropylaminoacarbonyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amide derivatives bearing a cyclopropylaminoacarbonyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives bearing a cyclopropylaminoacarbonyl... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2626811

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.